When should pharmaceutical companies grant compassionate use of experimental treatments? How readily available should the drugs be? A PBS news segment considers these issues.
When should pharmaceutical companies give gravely ill patients access to experimental treatments? The above news segment offers an good summary of the issues involved in this vexed ethical dilemma.
Compassionate Use Putting drug regulations to the test
- Can machines be moral? - March 7, 2021
- Can we synthesise Christianity moral theology with secular bioethics? - November 28, 2020
- Euthanasia polling data may fail to capture people’s considered views - August 15, 2020